Annual ROE
-70.62%
+8.18%+10.38%
31 December 2023
Summary:
Black Diamond Therapeutics annual return on equity is currently -70.62%, with the most recent change of +8.18% (+10.38%) on 31 December 2023. During the last 3 years, it has fallen by -48.77% (-223.20%). BDTX annual ROE is now -194.45% below its all-time high of 74.77%, reached on 31 December 2019.BDTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-68.08%
+1.00%+1.45%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly return on equity is currently -68.08%, with the most recent change of +1.00% (+1.45%) on 30 September 2024. Over the past year, it has increased by +10.09% (+12.91%). BDTX quarterly ROE is now -155.17% below its all-time high of 123.41%, reached on 30 June 2019.BDTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.4% | +12.9% |
| 3 y3 years | -223.2% | -47.2% |
| 5 y5 years | -222.9% | +27.6% |
BDTX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -223.2% | +10.4% | -47.2% | +12.9% |
| 5 y | 5 years | -194.4% | +10.4% | -237.5% | +72.1% |
| alltime | all time | -194.4% | +10.4% | -155.2% | +72.1% |
Black Diamond Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -68.08%(-1.4%) |
| June 2024 | - | -69.08%(-5.3%) |
| Mar 2024 | - | -72.94%(-4.6%) |
| Dec 2023 | -70.62%(-10.4%) | -76.43%(-2.2%) |
| Sept 2023 | - | -78.17%(+1.4%) |
| June 2023 | - | -77.11%(+11.3%) |
| Mar 2023 | - | -69.30%(+9.0%) |
| Dec 2022 | -78.80%(+22.9%) | -63.55%(+8.3%) |
| Sept 2022 | - | -58.68%(-0.8%) |
| June 2022 | - | -59.14%(+2.6%) |
| Mar 2022 | - | -57.63%(+8.6%) |
| Dec 2021 | -64.11% | -53.07%(+14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -46.24%(+28.2%) |
| June 2021 | - | -36.06%(+32.9%) |
| Mar 2021 | - | -27.14%(+34.6%) |
| Dec 2020 | -21.85%(-129.2%) | -20.17%(-9.5%) |
| Sept 2020 | - | -22.28%(-11.7%) |
| June 2020 | - | -25.22%(-25.9%) |
| Mar 2020 | - | -34.03%(-86.0%) |
| Dec 2019 | 74.77%(+30.1%) | -243.75%(+159.4%) |
| Sept 2019 | - | -93.98%(-176.2%) |
| June 2019 | - | 123.41%(+178.2%) |
| Mar 2019 | - | 44.36%(+124.8%) |
| Dec 2018 | 57.46%(-16.7%) | 19.73% |
| Dec 2017 | 68.94% | - |
FAQ
- What is Black Diamond Therapeutics annual return on equity?
- What is the all time high annual ROE for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual ROE year-on-year change?
- What is Black Diamond Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly ROE year-on-year change?
What is Black Diamond Therapeutics annual return on equity?
The current annual ROE of BDTX is -70.62%
What is the all time high annual ROE for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual return on equity is 74.77%
What is Black Diamond Therapeutics annual ROE year-on-year change?
Over the past year, BDTX annual return on equity has changed by +8.18% (+10.38%)
What is Black Diamond Therapeutics quarterly return on equity?
The current quarterly ROE of BDTX is -68.08%
What is the all time high quarterly ROE for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly return on equity is 123.41%
What is Black Diamond Therapeutics quarterly ROE year-on-year change?
Over the past year, BDTX quarterly return on equity has changed by +10.09% (+12.91%)